Promoted
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
Sesen Bio is a biotechnology business based in the US. Sesen Bio stocks (SESN.US) are listed on the NASDAQ and all prices are listed in US Dollars. Sesen Bio employs 17 staff and has a trailing 12-month revenue of around $40 million.
How to buy Sesen Bio stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SESN. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Promoted
Finder Award
Interactive Brokers
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
Sesen Bio stock price (NASDAQ:SESN)
Use our graph to track the performance of SESN stocks over time.Sesen Bio shares at a glance
Information last updated 2023-04-30.
| Latest market close | $0.00 |
|---|---|
| 52-week range | $0.24 - $19.30 |
| 50-day moving average | $0.60 |
| 200-day moving average | $0.62 |
| Wall St. target price | $12.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.10 |
Buy Sesen Bio stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Note: The dollar amounts in the table below are in Canadian dollars.
1 - 5 of 5
Is it a good time to buy Sesen Bio stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Sesen Bio price performance over time
Historical closes compared with the close of $0 from 2023-03-08
| 1 week (2023-05-21) | nan% |
|---|---|
| 1 month (2023-04-27) | nan% |
| 3 months (2023-03-01) | -100.00% |
| 6 months (2022-12-01) | -100.00% |
| 1 year (2022-06-01) | -100.00% |
|---|---|
| 2 years (2021-06-01) | -100.00% |
| 3 years (2020-06-01) | 0.802 |
| 5 years (2018-06-01) | 2.52 |
Sesen Bio financials
| Revenue TTM | $40 million |
|---|---|
| Gross profit TTM | $38 million |
| Return on assets TTM | -11.16% |
| Return on equity TTM | -12.06% |
| Profit margin | -49.71% |
| Book value | $0.78 |
| Market capitalisation | $128 million |
TTM: trailing 12 months
Sesen Bio share dividends
We're not expecting Sesen Bio to pay a dividend over the next 12 months.
Have Sesen Bio's shares ever split?
Sesen Bio's shares were split on a 1:20 basis on 8 March 2023. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Sesen Bio shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Sesen Bio shares which in turn could have impacted Sesen Bio's share price.
Sesen Bio share price volatility
Over the last 12 months, Sesen Bio's shares have ranged in value from as little as $0.2414 up to $19.3. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sesen Bio's is 0.8295. This would suggest that Sesen Bio's shares are less volatile than average (for this exchange).
Sesen Bio overview
Sesen Bio, Inc. , a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment of bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer; to treat non-muscle invasive carcinoma in situ of the bladder in patients previously treated with BCG; and for the treatment of squamous cell carcinoma of the head and neck, as well as VB6-845d, a product candidate for use in the treatment of various types of an anti-epithelial cell adhesion molecule-positive solid tumors. Sesen Bio, Inc. has an agreement with Leiden University Medical Center to co-develop an imaging agent. The company was formerly known as Eleven Biotherapeutics, Inc. and changed its name to Sesen Bio, Inc.
Stocks similar to Sesen Bio
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
Best stock app for beginners for 2023
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…More guides on Finder
-
Best bad credit loans in Prince Edward Island
Compare some of the best bad credit loans in PEI.
-
Credito review
Your guide to the features, interest rates and fees to expect when you apply for a short-term loan with Credito.
-
5 apps like Bree in Canada
Pay for unexpected bills and avoid overdrafts when you sign up for apps like Bree.
-
Debt Relief Canada (reliefcanada.ca) review
Take a closer look at the debt relief solutions, features and fees of Debt Relief Canada.
-
Desjardins Online Brokerage (Disnat) review 2023
Learn more about Desjardins Online Brokerage (Disnat) to see if it’s the right broker for you.
-
Guide to finding the best prepaid card in Canada in June 2023
We show you the best prepaid credit cards in Canada, whether you’re looking for a prepaid card with no fees, cash back rewards, or travel perks, or more.
-
How to buy Sui (SUI) in Canada
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
-
5 apps like Nyble in Canada
Compare apps like Nyble in Canada to access emergency funding.
-
RightRide review
Your guide to buying and financing a car in Canada with RightRide.
-
Compare bad credit car loans in BC
Your guide to bad credit car loans in BC and how to find the right financing for your needs.